Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteers

Journal of Clinical Pharmacology

Volumn 38, Issue 7, 1998, Pages 603-609

  Scavone, Joseph M ^a,b   Greenblatt, David J ^a   Harmatz, Jerold S ^a   Engelhardt, Nina ^a,c   Shader, Richard I ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

^c School of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; DOXYLAMINE; HYDROXYZINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HALF LIFE; DRUG LABELING; ELDERLY CARE; FEMALE; HEART RATE; HUMAN; HYPNOSIS; INFORMED CONSENT; MALE; MEMORY; MOOD; ORAL DRUG ADMINISTRATION; PSYCHOMOTOR ACTIVITY; SEDATION; SELF CONCEPT;

EID: 0031950428     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04466.x     Document Type: Article

References (39)

1. Tempero KF, Hunninghake DB: Antihistamines. Postgrad Med 1970;48:149-155.
2. Zepp EA, Thomas JA, Knotts GR: Some pharmacologic aspects of the antihistamines: a survey of current clinical applications. Clin Pediatr 1975;14:1119-1124.
3. 1-receptor antagonist drugs. New Engl J Med 1994;330:1663-1670.
4. Mant A, Whicker S, Kwok YS: Over-the-counter self-medication: the issues. Drugs Aging 1992;2:257-261.
5. Kupfer DJ, Reynolds CF: Management of insomnia. Af Engl J Med 1997;336:341-346.
6. 1-receptor antagonists (the antihistamines). Clin Pharmacokinet 1985;10: 477-497.
7. Blyden GT, Greenblatt DJ, Scavone JM, Shader RI: Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administration. J Clin Pharmacol 1986;26:529-523.
8. Albert KS, Hallmark MR, Sakmar E, Weidler DJ, Wagner JG: Pharmacokinetics of diphenhydramine in man. J Pharmacokinet Biopharm 1975;3:159-170.
9. Carruthers SG, Shoeman DW, Hignite CE, Azarnoff DL: Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin Pharmacol Ther 1978;23:375-382.
10. Berlinger WG, Goldberg MJ, Spector R, Chiang C-K, Ghoneim MM: Diphenhydramine: kinetics and psychomotor effects in elderly women. Clin Pharmacol Ther 1982;32:387-391.
11. Spector R, Choudury AK, Chiang C-K, Goldberg MJ, Ghoneim MM: Diphenhydramine in orientals and caucasians. Clin Pharmacol Ther 1980;28:229-234.
12. Meredith CG, Christian CD, Johnson RF, Madhavan SV, Schenker S: Diphenhydramine disposition in chronic liver disease. Clin Pharmacol Ther 1984;35:474-479.
13. Greenblatt DJ, Sellers EM, Shader RI: Drug disposition in old age. N Engl J Med 1982;306:1081-1088.
14. Greenblatt DJ, Harmatz JS, Shader RI: Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly: therapeutic considerations. Clin Pharmacokinet 1991;21:165-177, 262-273.
15. Durnas C, Loi C-M, Cusack BJ: Hepatic drug metabolism and aging. Clin Pharmacokinet 1990;19:359-389.
16. Loi C-M, Vestal RE: Drug metabolism in the elderly. Pharmacol Ther 1988;36:131-149.
17. Simons KJ, Watson WTA, Martin TJ, Chen XY, Simons FER: Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children. J Clin Pharmacol 1990; 30:665-671.
18. Friedman H, Greenblatt DJ, Scavone JM, Burstein ES, Ochs HR, Harmatz JS, Shader RI: Clearance of the antihistamine doxylamine: reduced in elderly men but not elderly women. Clin Pharmacokinet 1989;16:312-316.
19. 1-receptor antagonist hydroxyzine in the elderly. Clin Pharmacol Ther 1989;45:9-14.
20. Saletu B, Grünberger J, Krupka M, Schuster P: Comparative double-blind, placebo-controlled sleep laboratory studies of a combination of lorazepam and diphenhydramine (SM-1014) and its single components. Curr Ther Res 1987;42:1037-1058.
21. Roth T, Roehrs T, Koshorek G, Sicklesteel J, Zorick F: Sedative effects of antihistamines. J Allergy Clin Immunol 1987;80:94-98.
22. Rickels K, Morris RJ, Newman H, Rosenfeld H, Schiller H, Weinstock R: Diphenhydramine in insomniac family practice patients: a double-blind study. J Clin Pharmacol 1983;23:235-242.
23. Teutsch G, Mahler DL, Brown CR, Forrest WH, James KE, Brown BW: Hypnotic efficacy of diphenhydramine, methapyrilene, and pentobarbital. Clin Pharmacol Ther 1975;17:195-201.
24. Sunshine A, Zighelboim I, Laska E: Hypnotic activity of diphenhydramine, methapyrilene, and placebo. J Clin Pharmacol 1978;18:425-431.
25. Rombaut NEI, Hindmarch I: Psychometric aspects of antihistamines: a review. Hum Psychopharmacol 1994;9:157-169.
26. 1-receptor antagonists: comparative tolerability and safety. Drug Safety 1994;10:350-380.
27. Cohen AF, Posner J, Ashby L, Smith R, Peck AW: A comparison of methods for assessing the sedative effects of diphenhydramine on skills related to car driving. Eur J Clin Pharmacol 1984; 27:477-482.
28. Fine BJ, Kobrick JL, Lieberman HR, Marlowe B, Riley RH, Tharion WJ: Effects of caffeine or diphenhydramine on visual vigilance. Psychopharmacology 1994;114:233-238.
29. Greenblatt DJ, Harmatz JS, Shapiro L, Englehardt N, Gouthro TA, Shader RI: Sensitivity to triazolam in the elderly. New Engl J Med 1991;324:1691-1698.
30. Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau MM, Harmatz JS, Shader RI: Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol 1997;37:693-703.
31. Lapierre KA, Greenblatt DJ, Goddard JE, Harmatz JS, Shader RI: The neuropsychiatric effects of aspartame in normal volunteers. J Clin Pharmacol 1990;30:454-460.
32. Abernethy DR, Greenblatt DJ: Diphenhydramine determination in human plasma by gas-liquid chromatography using nitrogen-phosphorus detection: application to single low-dose pharmacokinetic studies. J Pharm Sci 1983;72:941-943.
33. Starmer G: Antihistamines and highway safety. Accident Anal Prevention 1985;17:311-317.
34. Gengo F, Gabos C, Miller KJ: The pharmacodynamics of diphenhydramine-induced drowsiness and changes in mental performance. Clin Pharmacol Ther 1989;45:15-21.
35. Luna BG, Scavone JM, Greenblatt DJ: Doxylamine and diphenhydramine pharmacokinetics in women on low-dose estrogen oral contraceptives. J Clin Pharmacol 1989;29:257-260.
36. Greenblatt DJ, Harmatz JS, Gouthro TA, Locke J, Shader RI: Distinguishing a benzodiazepine agonist (triazolam) from a non-agonist anxiolytic (buspirone) by electroencephalography: kinetic-dynamic studies. Clin Pharmacol Ther 1994;56:100-111.
37. Greenblatt DJ, Scavone JM, Harmatz JS, Englehardt N, Shader RJ: Cognitive effects of β-adrenergic antagonists after single doses: pharmacokinetics and pharmacodynamics of propranolol, atenolol, lorazepam, and placebo. Clin Pharmacol Ther 1993;53:577-584.
38. Greenblatt DJ, Harmatz JS, Engelhardt N, Shader RI: Pharmacokinetic determinants of dynamic differences among three benzodiazepine hypnotics: flurazepam, temazepam, and triazolam. Arch Gen Psychiatry 1989;46:326-332.
39. Greenblatt DJ, Harmatz JS, Dorsey C, Shader RI: Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo. Clin Pharmacol Ther 1988;44:326-334.